Relmada Therapeutics Inc
F:4E2
Relmada Therapeutics Inc
F:4E2
Price:
6.5
EUR
6.56%
Market Closed
Market Cap:
€195.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
Rush Enterprises Inc
F:RUN
|
US |
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
I
|
Informa PLC
F:IEA
|
UK |
|
C
|
Continental AG
DUS:CON
|
DE |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
Wall St Price Targets
Price Targets Summary
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Wall Street analysts forecast Relmada Therapeutics Inc stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for Relmada Therapeutics Inc is 3.42 EUR with a low forecast of 2.46 EUR and a high forecast of 4.86 EUR.
Lowest Forecast
Price Target
2.46
EUR
62% Downside
Average Forecast
Price Target
3.42
EUR
47% Downside
Highest Forecast
Price Target
4.86
EUR
25% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Relmada Therapeutics Inc's stock price target?
Price Target
3.42
EUR
3.42
EUR
According to Wall Street analysts, the average 1-year price target for Relmada Therapeutics Inc is 3.42 EUR with a low forecast of 2.46 EUR and a high forecast of 4.86 EUR.
